Skip to main content
Erschienen in: Metabolic Brain Disease 3-4/2007

01.12.2007 | Original Paper

New findings on cerebral ammonia uptake in HE using functional 13N-ammonia PET

verfasst von: Michael Sørensen, Susanne Keiding

Erschienen in: Metabolic Brain Disease | Ausgabe 3-4/2007

Einloggen, um Zugang zu erhalten

Abstract

PET is a functional imaging technique suitable for studies of brain ammonia metabolism. Dynamic 13N-ammonia PET yields time-courses of radioactivity concentrations in brain (PET camera) and blood (samples). Ahl et al. (Hepatology 40:73–79, 2004) and Keiding et al. (Hepatology 43:42–50, 2006) analysed such data in patients with HE by a kinetic model accounting for transfer of 13N-ammonia across the blood–brain barrier (BBB) and intracellular formation of 13N-glutamine. Initial unidirectional 13N-ammonia transfer across BBB was characterized by the permeability-surface area product PSBBB (ml blood min−1 ml−1 tissue). There was a tendency to lower PSBBB values in patients with cirrhosis and HE than in patients with cirrhosis without HE and healthy controls but the differences were not statistically significant. Keiding et al. (Hepatology 43:42–50, 2006) also calculated PSmet (ml blood min−1 ml−1 tissue) as a measure of the combined transfer of 13N-ammonia across BBB and subsequent intracellular metabolism of 13N-ammonia; neither did this PS-value show significant difference between the groups of subjects. Net flux of ammonia from blood into intracellular metabolites was linearly correlated to arterial ammonia. In conclusion, basic brain ammonia kinetics was not changed significantly in patients with cirrhosis +/- HE compared to healthy controls. Blood ammonia seems to be the more important factor for increased brain ammonia uptake in HE.
Literatur
Zurück zum Zitat Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Köstler H, Hecker H, Burchert W (2004) Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79PubMedCrossRef Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Köstler H, Hecker H, Burchert W (2004) Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79PubMedCrossRef
Zurück zum Zitat Crone C (1964) Permeability of capillaries in various organs as determined by use of the indicator diffusion method. Acta Physiol Scand 58:292–305CrossRef Crone C (1964) Permeability of capillaries in various organs as determined by use of the indicator diffusion method. Acta Physiol Scand 58:292–305CrossRef
Zurück zum Zitat Goldbecker A (2007, this conference) Cerebral ammonia metabolism in liver fibrosis. In: Metabolic brain disease (eds. xxx); in press Goldbecker A (2007, this conference) Cerebral ammonia metabolism in liver fibrosis. In: Metabolic brain disease (eds. xxx); in press
Zurück zum Zitat Keiding S, Sørensen M (2007) Hepatic removal kinetics: importance for quantitative measurements of liver function. In: Rhodés J, Benhamou JP, Blei A, Reichen J, Rizzetto M, (eds.) Textbook of hepatology: from basic science to clinical practice, 3rd edn. Blackwell, pp 468–478 Keiding S, Sørensen M (2007) Hepatic removal kinetics: importance for quantitative measurements of liver function. In: Rhodés J, Benhamou JP, Blei A, Reichen J, Rizzetto M, (eds.) Textbook of hepatology: from basic science to clinical practice, 3rd edn. Blackwell, pp 468–478
Zurück zum Zitat Keiding S, Munk OL, Schiøtt KM, Hansen SB (2000) Dynamic 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography of liver tumors without blood sampling. Eur J Nucl Med 27:407–412PubMedCrossRef Keiding S, Munk OL, Schiøtt KM, Hansen SB (2000) Dynamic 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography of liver tumors without blood sampling. Eur J Nucl Med 27:407–412PubMedCrossRef
Zurück zum Zitat Keiding S, Sørensen M, Bender D, Munk OL, Ott P, Vilstrup H (2006) Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by PET. Hepatology 43:42–50PubMedCrossRef Keiding S, Sørensen M, Bender D, Munk OL, Ott P, Vilstrup H (2006) Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by PET. Hepatology 43:42–50PubMedCrossRef
Zurück zum Zitat Kety SS (1951). The theory and application of the exchange of inert gas at lung and tissues. Pharmacol Rev 3:1–41PubMed Kety SS (1951). The theory and application of the exchange of inert gas at lung and tissues. Pharmacol Rev 3:1–41PubMed
Zurück zum Zitat Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, Plum F (1979) The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest 63:449–460PubMedCrossRef Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, Plum F (1979) The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest 63:449–460PubMedCrossRef
Zurück zum Zitat Lockwood AH, Bolomey L, Napoleon F (1984) Blood–brain barrier to ammonia in humans. J Cereb Blood Flow Metab 4:516–522PubMed Lockwood AH, Bolomey L, Napoleon F (1984) Blood–brain barrier to ammonia in humans. J Cereb Blood Flow Metab 4:516–522PubMed
Zurück zum Zitat Lockwood AH, Yap EW, Wong WH (1991) Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 11:337–341PubMed Lockwood AH, Yap EW, Wong WH (1991) Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 11:337–341PubMed
Zurück zum Zitat Ott P, Larsen FS (2004) Blood–brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int 40:185–198CrossRef Ott P, Larsen FS (2004) Blood–brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int 40:185–198CrossRef
Zurück zum Zitat Phelps ME, Hoffman EJ, Coleman RE, Welch MJ, Raichle ME, Weiss ES (1976) Tomographic images of blood pool and perfusion in brain and heart. J Nucl Med 17:603–612PubMed Phelps ME, Hoffman EJ, Coleman RE, Welch MJ, Raichle ME, Weiss ES (1976) Tomographic images of blood pool and perfusion in brain and heart. J Nucl Med 17:603–612PubMed
Zurück zum Zitat Phelps ME, Huang SC, Hoffman EJ, Selin C, Kuhl DE (1981) Cerebral extraction of 13N-ammonia: its dependence on cerebral blood flow and capillary permeability-surface area product. Stroke 12:607–619PubMed Phelps ME, Huang SC, Hoffman EJ, Selin C, Kuhl DE (1981) Cerebral extraction of 13N-ammonia: its dependence on cerebral blood flow and capillary permeability-surface area product. Stroke 12:607–619PubMed
Zurück zum Zitat Renkin EM (1959) Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 197:1205–1210PubMed Renkin EM (1959) Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 197:1205–1210PubMed
Zurück zum Zitat Rosenspire KC, Schwaiger M, Mangner TJ, Hutchins GD, Sutorik A, Kuhl DE (1990) Metabolic fate of [13N]ammonia in human and canine blood. J Nucl Med 31:163–167PubMed Rosenspire KC, Schwaiger M, Mangner TJ, Hutchins GD, Sutorik A, Kuhl DE (1990) Metabolic fate of [13N]ammonia in human and canine blood. J Nucl Med 31:163–167PubMed
Zurück zum Zitat Sørensen M, Keiding S (2006a) Ammonia metabolism in cirrhosis. In: Häussinger D, Kircheis G, Schliess F (Eds) Hepatic encephalopathy and nitrogen metabolism. Springer, pp 406–419 Sørensen M, Keiding S (2006a) Ammonia metabolism in cirrhosis. In: Häussinger D, Kircheis G, Schliess F (Eds) Hepatic encephalopathy and nitrogen metabolism. Springer, pp 406–419
Zurück zum Zitat Sørensen M, Keiding S (2006b) Reply to letter to the Editor by Lockwood A, Wack D. The brain permeability-surface product for ammonia. Hepatology 44:1053–1054 Sørensen M, Keiding S (2006b) Reply to letter to the Editor by Lockwood A, Wack D. The brain permeability-surface product for ammonia. Hepatology 44:1053–1054
Zurück zum Zitat Sørensen M, Keiding S (2007) Positron emission tomography of the liver. In: Rhodés J, Benhamou JP, Blei A, Reichen J, Rizzetto M (eds) Textbook of hepatology: from basic science to clinical practice, 3rd edn. Blackwell, pp 561–566 Sørensen M, Keiding S (2007) Positron emission tomography of the liver. In: Rhodés J, Benhamou JP, Blei A, Reichen J, Rizzetto M (eds) Textbook of hepatology: from basic science to clinical practice, 3rd edn. Blackwell, pp 561–566
Zurück zum Zitat Weissenborn K, Bokemeyer M, Ahl B, Fischer-Wasels D, Giewekemeyer K, van den Hoff J, Köstler G, Berding G (2004) Functional imaging of the brain in patients with liver cirrhosis. Metab Brain Dis 19:269–280PubMedCrossRef Weissenborn K, Bokemeyer M, Ahl B, Fischer-Wasels D, Giewekemeyer K, van den Hoff J, Köstler G, Berding G (2004) Functional imaging of the brain in patients with liver cirrhosis. Metab Brain Dis 19:269–280PubMedCrossRef
Metadaten
Titel
New findings on cerebral ammonia uptake in HE using functional 13N-ammonia PET
verfasst von
Michael Sørensen
Susanne Keiding
Publikationsdatum
01.12.2007
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 3-4/2007
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-007-9066-1

Weitere Artikel der Ausgabe 3-4/2007

Metabolic Brain Disease 3-4/2007 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.